Yes, Multiple Moderate-to-Large Emboli Involving Lobar and Segmental Arteries is Typical for Pulmonary Embolism
The presentation described—several moderate-to-large emboli in both lungs involving multiple lobar and segmental arteries—represents a common pattern of acute PE, with segmental involvement occurring in approximately 86% of cases and lobar involvement in 41% of acute PE patients 1.
Distribution Pattern Analysis
The bilateral, multi-level involvement you describe aligns with typical PE patterns:
- Segmental arteries are the most frequently involved (86% of cases), followed by lobar arteries (41%) 1
- Bilateral PE occurs in approximately 65% of cases, making it more common than unilateral involvement 1
- Multiple emboli are the norm rather than the exception—in one study, saddle emboli (which extend across vessel bifurcations) were present in 67% of PE patients, with patients having 1-10 saddle emboli each 2
The lower lobe branches (right 55%, left 53%) and upper lobe branches (right 47%, left 41%) are the most common anatomic sites 1.
Clinical Significance vs. Thrombus Burden
A critical caveat: The number and location of clots does NOT reliably predict mortality or guide treatment decisions 3. The 2026 AHA/ACC guidelines explicitly recommend against using quantification of angiographic thrombus burden for short-term risk stratification (Class 3: No Benefit recommendation) 3.
Key evidence supporting this:
- A meta-analysis of 19 studies found no direct correlation between high obstruction index and prognosis; paradoxically, lower obstruction indices showed increased mortality (OR 2.24) 3
- A prospective study of 271 PE patients showed no association between thrombus burden and adverse clinical events after excluding hemodynamically unstable patients 3
- Clot volume measurements, while strongly correlated with semiquantitative scores, were not independently associated with short-term mortality 4
What Actually Matters for Risk Stratification
Instead of counting clots, focus on:
- Hemodynamic status (presence of shock or hypotension)
- Right ventricular dysfunction on imaging (RV/LV ratio >1.0 is the only CT finding independently associated with mortality) 4
- Biomarkers (troponin, BNP/NT-proBNP)
- Clinical risk scores (not anatomic burden)
The 2026 PE-RADS reporting system emphasizes anatomic location (central vs. peripheral) and right heart function assessment rather than clot counting 5.
Practical Implications
While this patient's multi-level bilateral involvement is typical, treatment decisions should be based on the AHA/ACC PE Categories (A-E) that incorporate hemodynamics, biomarkers, and RV function—not on the number or size of visible clots 3, 6. The anatomic characterization becomes relevant only when considering advanced therapies (catheter-directed intervention, surgical embolectomy) in selected high-risk patients 3.